Screening
Screening in the general population is not practical.
Screening populations with high prevalence of glucose-6-phosphate dehydrogenase deficiency (e.g., Kurdish Jews, in whom prevalence is 50% to 70%) could be considered.[46]
Universal newborn screening programs in the US and Canada screen for sickle cell disease.
Use of this content is subject to our disclaimer